Clarification Appended A Wednesday (March 15) court hearing to determine the future of access to the abortion pill, mifepristone, will tackle FDA’s accelerated approval regulations, pediatric study requirements for drugs and whether federal law allows mailing of medication abortion, the judge informed the attorneys in the case. The hearing is part of a high-profile suit that could reverse FDA’s more than 20-year-long approval of mifepristone -- one of two pills used as part of a medication abortion...